Literature DB >> 17221848

Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression.

Francesco Benedetti1, Sara Dallaspezia, Mara Cigala Fulgosi, Cristina Lorenzi, Alessandro Serretti, Barbara Barbini, Cristina Colombo, Enrico Smeraldi.   

Abstract

Depressive insomnia and diurnal fluctuations of mood and activity are core clinical features of mood disorders. Here we studied the effect of CLOCK 3111 T/C SNP (rs1801260) on the actimetric recorded diurnal activity and nocturnal sleep of 39 bipolar depressed inpatients. Compared to T/T homozygotes, carriers of the C allele had a similar degree of severity of depression, but showed higher activity levels in the evening, a delayed sleep onset (mean 79 min later), and a reduced amount of sleep during the night (mean 75 min less). Ongoing lithium treatment significantly interacted with rs1801260 by enhancing activity levels in the evening and reducing the differences among genotype groups. Individual characteristics of the molecular clock can influence sleep symptoms in mood disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221848     DOI: 10.1002/ajmg.b.30475

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  63 in total

Review 1.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

Review 2.  Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder.

Authors:  Elena Ivleva; Gunvant Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2008-05-30       Impact factor: 9.306

Review 3.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 4.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

5.  Dendritic cell nuclear protein-1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N-acetyltransferase in C6 cells.

Authors:  Dong Chen; Yi-Pei Li; Yan-Xia Yu; Tian Zhou; Chao Liu; Er-Kang Fei; Feng Gao; Chen-Chen Mu; Hai-Gang Ren; Guang-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

6.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

7.  Genome-wide association scan for five major dimensions of personality.

Authors:  A Terracciano; S Sanna; M Uda; B Deiana; G Usala; F Busonero; A Maschio; M Scally; N Patriciu; W-M Chen; M A Distel; E P Slagboom; D I Boomsma; S Villafuerte; E Sliwerska; M Burmeister; N Amin; A C J W Janssens; C M van Duijn; D Schlessinger; G R Abecasis; P T Costa
Journal:  Mol Psychiatry       Date:  2008-10-28       Impact factor: 15.992

8.  ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality.

Authors:  Leena Kovanen; Sirkku T Saarikoski; Arpo Aromaa; Jouko Lönnqvist; Timo Partonen
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

9.  CLOCK is suggested to associate with comorbid alcohol use and depressive disorders.

Authors:  Louise K Sjöholm; Leena Kovanen; Sirkku T Saarikoski; Martin Schalling; Catharina Lavebratt; Timo Partonen
Journal:  J Circadian Rhythms       Date:  2010-01-21

Review 10.  Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review.

Authors:  M Kristensen; A A Nierenberg; S D Østergaard
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.